Hired and Retired: Transitions at the top
In a significant move at the larger end of the biopharma world, AstraZeneca’s global VP of cardiovascular, renal and metabolism made the move to Novo Nordisk to head up its biopharm unit.
Another move saw a boost to the number of women working in leadership positions in the biopharma industry, with the appointment of Vanessa King and Isabel Najera at newly formed biotech, Virion Biotherapeutics.
For these appointments and more, click through the gallery:
Hired and Retired: Transitions at the top Novo Nordisk: Ludovic Helfgott Redpin Therapeutics: David Bleakman Virion: Vanessa King and Isabel Najera AMR: Emile Nuwaysir F-Star: Eliot Forster